These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8406414)

  • 1. Cytokines in malignant lymphomas: review and prospective evaluation.
    Hsu SM; Waldron JW; Hsu PL; Hough AJ
    Hum Pathol; 1993 Oct; 24(10):1040-57. PubMed ID: 8406414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine and paracrine functions of cytokines in malignant lymphomas.
    Hsu SM; Hsu PL
    Biomed Pharmacother; 1994; 48(10):433-44. PubMed ID: 7858153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.
    Merz H; Fliedner A; Orscheschek K; Binder T; Sebald W; Müller-Hermelink HK; Feller AC
    Am J Pathol; 1991 Nov; 139(5):1173-80. PubMed ID: 1951632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
    Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
    Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classical Hodgkin's lymphoma: biology and grey zones].
    Gaulard P; Brousse N
    Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease.
    Van Gool SW; Delabie J; Vandenberghe P; Coorevits L; De Wolf-Peeters C; Ceuppens JL
    Leukemia; 1997 Jun; 11(6):846-51. PubMed ID: 9177439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas.
    Hsu SM; Xie SS; Waldron JA
    Am J Pathol; 1992 Oct; 141(4):915-23. PubMed ID: 1415484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
    Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
    Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
    Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
    Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma.
    Merz H; Houssiau FA; Orscheschek K; Renauld JC; Fliedner A; Herin M; Noel H; Kadin M; Mueller-Hermelink HK; Van Snick J
    Blood; 1991 Sep; 78(5):1311-7. PubMed ID: 1908723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and malignant lymphomas].
    Feller AC; Merz H
    Verh Dtsch Ges Pathol; 1992; 76():70-8. PubMed ID: 1283279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas.
    Hsu SM; Waldron J; Xie SS; Hsu PL
    J Biomed Sci; 1995 Oct; 2(4):302-313. PubMed ID: 11725067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
    Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
    Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma.
    Hsu SM; Waldron JA; Fink L; King C; Xie SS; Mansouri A; Barlogie B
    Hum Pathol; 1993 Feb; 24(2):126-31. PubMed ID: 8432509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.